AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, LinkedIn or Instagram.
His tenure at LinkedIn followed a period of rapid growth at the company, where it doubled down on diversifying its revenues into advertising alongside subscriptions to its premium and recruitment businesses, a major refresh of the company’s mobile effort, a number of redesigns and experiments across the main platform to best leverage the position that it holds among its user base — based on some of the same social mechanics that underpin the likes of Facebook, but with a much more practical, professional, productivity bent — and, most of all, very torrid growth of its user base. Some love to poke it and lampoon its somewhat surprising ability to infer your connections and send countless attempts to your email to try to engage you more, but ultimately it’s a tool and platform that hasn’t really found a strong single competitor.
Facebook receives plenty of pointed criticism from numerous corners, for refusing to police political speech on Facebook, its seemingly endless string of privacy breaches, and its apparent coziness of late with the Trump administration.